These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35388624)

  • 1. Proteome and secretome analysis of pancreatic cancer cells.
    Li X; Liu H; Dun MD; Faulkner S; Liu X; Jiang CC; Hondermarck H
    Proteomics; 2022 Jul; 22(13-14):e2100320. PubMed ID: 35388624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretome protein signature of human pancreatic cancer stem-like cells.
    Brandi J; Dalla Pozza E; Dando I; Biondani G; Robotti E; Jenkins R; Elliott V; Park K; Marengo E; Costello E; Scarpa A; Palmieri M; Cecconi D
    J Proteomics; 2016 Mar; 136():1-12. PubMed ID: 26850699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SWATH-MS proteomics of PANC-1 and MIA PaCa-2 pancreatic cancer cells allows identification of drug targets alternative to MEK and PI3K inhibition.
    Aguilar-Valdés A; Noriega LG; Tovar AR; Ibarra-Sánchez MJ; Sosa-Hernández VA; Maravillas-Montero JL; Martínez-Aguilar J
    Biochem Biophys Res Commun; 2021 May; 552():23-29. PubMed ID: 33740661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Proteomics Reveals Temporal Proteomic Changes in Signaling Pathways during BV2 Mouse Microglial Cell Activation.
    Woo J; Han D; Wang JI; Park J; Kim H; Kim Y
    J Proteome Res; 2017 Sep; 16(9):3419-3432. PubMed ID: 28777000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers.
    Makawita S; Smith C; Batruch I; Zheng Y; Rückert F; Grützmann R; Pilarsky C; Gallinger S; Diamandis EP
    Mol Cell Proteomics; 2011 Oct; 10(10):M111.008599. PubMed ID: 21653254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.
    Byers LA; Wang J; Nilsson MB; Fujimoto J; Saintigny P; Yordy J; Giri U; Peyton M; Fan YH; Diao L; Masrorpour F; Shen L; Liu W; Duchemann B; Tumula P; Bhardwaj V; Welsh J; Weber S; Glisson BS; Kalhor N; Wistuba II; Girard L; Lippman SM; Mills GB; Coombes KR; Weinstein JN; Minna JD; Heymach JV
    Cancer Discov; 2012 Sep; 2(9):798-811. PubMed ID: 22961666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitization of epidermal growth factor receptor/HER2-positive pancreatic cancer is mediated by inhibition of Akt independent of ras mutational status.
    Kimple RJ; Vaseva AV; Cox AD; Baerman KM; Calvo BF; Tepper JE; Shields JM; Sartor CI
    Clin Cancer Res; 2010 Feb; 16(3):912-23. PubMed ID: 20103665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The secretome signature of malignant mesothelioma cell lines.
    Manfredi M; Martinotti S; Gosetti F; Ranzato E; Marengo E
    J Proteomics; 2016 Aug; 145():3-10. PubMed ID: 26921831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor-related protein inhibits cell growth and induces apoptosis of BxPC3 pancreatic cancer cells.
    Zhang Y; Banerjee S; Wang ZW; Marciniak DJ; Majumdar AP; Sarkar FH
    Cancer Res; 2005 May; 65(9):3877-82. PubMed ID: 15867387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of pancreatic cancer stem cells: Functional role of fatty acid synthesis and mevalonate pathways.
    Brandi J; Dando I; Pozza ED; Biondani G; Jenkins R; Elliott V; Park K; Fanelli G; Zolla L; Costello E; Scarpa A; Cecconi D; Palmieri M
    J Proteomics; 2017 Jan; 150():310-322. PubMed ID: 27746256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic Analysis of MYB-Regulated Secretome Identifies Functional Pathways and Biomarkers: Potential Pathobiological and Clinical Implications.
    Zubair H; Patel GK; Khan MA; Azim S; Zubair A; Singh S; Srivastava SK; Singh AP
    J Proteome Res; 2020 Feb; 19(2):794-804. PubMed ID: 31928012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer.
    Young CD; Zimmerman LJ; Hoshino D; Formisano L; Hanker AB; Gatza ML; Morrison MM; Moore PD; Whitwell CA; Dave B; Stricker T; Bhola NE; Silva GO; Patel P; Brantley-Sieders DM; Levin M; Horiates M; Palma NA; Wang K; Stephens PJ; Perou CM; Weaver AM; O'Shaughnessy JA; Chang JC; Park BH; Liebler DC; Cook RS; Arteaga CL
    Mol Cell Proteomics; 2015 Jul; 14(7):1959-76. PubMed ID: 25953087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative secretome analysis reveals the interactions between epithelia and tumor cells by in vitro modulating colon cancer microenvironment.
    Zeng X; Yang P; Chen B; Jin X; Liu Y; Zhao X; Liang S
    J Proteomics; 2013 Aug; 89():51-70. PubMed ID: 23748022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation.
    Liu X; Li X; Chen L; Hsu AC; Asquith KL; Liu C; Laurie K; Barr I; Foster PS; Yang M
    Front Immunol; 2022; 13():805558. PubMed ID: 35280986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YM155 induces EGFR suppression in pancreatic cancer cells.
    Na YS; Yang SJ; Kim SM; Jung KA; Moon JH; Shin JS; Yoon DH; Hong YS; Ryu MH; Lee JL; Lee JS; Kim TW
    PLoS One; 2012; 7(6):e38625. PubMed ID: 22723871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of dissociation factors in pancreatic Cancer using a mass spectrometry-based proteomic approach.
    Liu P; Kong L; Liang K; Wu Y; Jin H; Song B; Tan X
    BMC Cancer; 2020 Jan; 20(1):45. PubMed ID: 31959150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tanshinone IIA can inhibit MiaPaCa‑2 human pancreatic cancer cells by dual blockade of the Ras/Raf/MEK/ERK and PI3K/AKT/mTOR pathways.
    Su CC
    Oncol Rep; 2018 Nov; 40(5):3102-3111. PubMed ID: 30226540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach.
    Grønborg M; Kristiansen TZ; Iwahori A; Chang R; Reddy R; Sato N; Molina H; Jensen ON; Hruban RH; Goggins MG; Maitra A; Pandey A
    Mol Cell Proteomics; 2006 Jan; 5(1):157-71. PubMed ID: 16215274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells.
    Müller KM; Tveteraas IH; Aasrum M; Ødegård J; Dawood M; Dajani O; Christoffersen T; Sandnes DL
    BMC Cancer; 2011 Oct; 11():421. PubMed ID: 21961726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into erlotinib action in pancreatic cancer cells using a combined experimental and mathematical approach.
    Lange F; Rateitschak K; Kossow C; Wolkenhauer O; Jaster R
    World J Gastroenterol; 2012 Nov; 18(43):6226-34. PubMed ID: 23180942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.